dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:21:56Z
dc.date.accessioned2022-10-05T18:02:34Z
dc.date.available2014-05-27T11:21:56Z
dc.date.available2022-10-05T18:02:34Z
dc.date.created2014-05-27T11:21:56Z
dc.date.issued2006-08-09
dc.identifierJournal of the Brazilian Chemical Society, v. 17, n. 4, p. 674-679, 2006.
dc.identifier0103-5053
dc.identifierhttp://hdl.handle.net/11449/69028
dc.identifier10.1590/S0103-50532006000400007
dc.identifierS0103-50532006000400007
dc.identifierWOS:000239616800006
dc.identifier2-s2.0-33746702584
dc.identifier2-s2.0-33746702584.pdf
dc.identifier5978908591853524
dc.identifier3192125098361121
dc.identifier0000-0003-0197-7369
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3918526
dc.description.abstractThis paper describes a very simple and rapid quantitative reflectance spot test procedure for the determination of methyldopa in pharmaceutical formulations. This method is based on the complexation reaction of methyldopa with molybdate ions yielding a yellow stable complex on filter paper. Reflectance measurements were carried out at 410 nm. Under optimal conditions, the calibration graphs obtained for methyldopa by plotting the optical density of the reflectance signal (A R) vs. the log of the concentration were linear from 6.30 × 10 -3 to 1.89 × 10 -2 mol L -1, with a correlation coefficient of 0.998. The detection limit was 2.74 × 10 -3 mol L -1 (R.S.D. = 1.02%) for methyldopa. The common excipients used as additives in pharmaceuticals do not interfere in the proposed method. The method was applied to determine metyldopa in commercial pharmaceutical formulations. The results obtained by the proposed method compare favorably with those obtained by an official procedure at 95% confidence level. ©2006 Sociedade Brasileira de Química.
dc.languageeng
dc.relationJournal of the Brazilian Chemical Society
dc.relation70078
dc.relation1.444
dc.relation0,357
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectDiffuse reflectance
dc.subjectMethyldopa
dc.subjectPharmaceuticals formulations
dc.titleDetermination of methyldopa in pharmaceutical formulations by combined spot test-diffuse reflectance spectroscopy
dc.typeArtigo


Este ítem pertenece a la siguiente institución